Novel Therapeutic Technologies

company

About

Novel Therapeutic Technology develops practical drug delivery systems.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$75M
Industries
Biotechnology,Health Care,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2003
Number Of Employee
11 - 50
Operating Status
Active

Novel Therapeutic Technology Inc. (NTT) is a leading pioneer in the development of sophisticated and practical drug delivery systems. NTT’s Ethosome technology provides the means to significantly enhance drug penetration of topical delivery applications, exponentially increasing therapeutic efficiency. With worldwide recognized drugs combined with NTT know-how, Pharmaceutical companies are able to introduce new and better drugs to the market, thus greatly reducing side effects, improving patient compliance, and increasing the patient's quality of life.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$75M
Novel Therapeutic Technologies has raised a total of $75M in funding over 2 rounds. Their latest funding was raised on Dec 19, 2011 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 19, 2011 Series Unknown $75M 1 Access BridgeGap Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Novel Therapeutic Technologies is funded by 1 investors. Access BridgeGap Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Access BridgeGap Ventures Yes Series Unknown